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Abstract
 .Biphalin, Tyr–D-Ala–Gly–Phe–NH , is a highly potent dimeric analog of enkephalin. Its analgesic efficacy is due in2
part to its ability to permeate the blood–brain barrier. To aid in understanding the mechanism of the transmembrane
movement we determined and analyzed the permeability and partition coefficients of biphalin and a series of analogues
where F, Cl, I, NO , or NH were placed in the para position of the aromatic rings of Phe4,4
X
. Liposomes composed of2 2
neutral phospholipids and cholesterol were used as the model membrane. The overall good correlation between permeability
and water-membrane partition coefficients suggests that the movement of biphalins across the model membrane is
controlled by diffusion and depends on the water-membrane partition coefficient. To explain the observed correlation
between permeability and the electron withdrawingrdonating character of the substituents in the phenylalanine ring, we
examined various folding patterns of Leu–enkephalin, an endogenous pentapeptide that exhibits affinities toward the same
 .classes of opioid receptors d and m . The observed permeabilities and partition coefficients of biphalin and analogues, as
well as the tyrosine side chain accessibility, are consistent with the presence of the type of folding where the tyrosine and
phenylalanine side chains are in a close contact. We propose that the aromatic ring interaction can promote the peptide
permeability by stabilizing a more compact structure of biphalin that would minimize the number of hydrogen bonds with
water and therefore enhances partitioning into the model membrane. q 1997 Elsevier Science B.V.
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Abbreviations: DPPC, 1,2-dipalmitoylphosphatidylcholine;
POPC, 1-palmitoyl-2-oleoylphosphatidylcholine; POPE, 1-palmi-
toyl-2-oleoylphosphatidylethanolamine; biphalin, Tyr–D-Ala–
.Gly–Phe–NH ; DSC, differential scanning calorimetry; T , gel2 m
to liquid-crystalline phase transition temperature measured as the
.temperature at the maximum of excess heat capacity ; D H ,cal
calorimetric enthalpy of the lipid phase transition; D H , Van’tvH
Hoff enthalpy of the lipid phase transition; CU, size of the
 .cooperative unit calculated as CUsD H rD H ; P, perme-vH cal
ability coefficient; K , water–membrane partition coefficient of
peptides
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1. Introduction
A major question of importance to medicine, phar-
macology, cell biology, and biological chemistry is
the nature of diffusion and transport of molecular
species across cell membranes. Concepts of mem-
brane transport and diffusion have evolved with the
increased understanding of the structure of cell mem-
 w x.branes see monographs 1,2 . The movement of
species across the membrane is accomplished either
by passive diffusion across the membrane or by some
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facilitated transport process, which may be associated
with a membrane protein or a smaller transport
molecule. Although mediated transport processes are
especially important to the natural functioning of the
cell, these transport processes are frequently not
available for the membrane movement of added phar-
macological agents. Thus, diffusion is the primary
process of membrane translocation for many thera-
peutic agents from the blood stream into various
regions of the body including the brain.
According to the diffusion model for membrane
transport, permeability coefficients are related to the
product of the water–membrane partition coefficient
of the permeant and the normal component of the
w xdiffusion coefficient 3 . The coefficient of partition
between polar and bulk nonpolar phases is a founda-
w xtion of the hydrophobicity scale of amino acids 4 .
Conveniently, this hydrophobicity scale can be re-
lated to the accessible surface area of the given
w xamino acid residue 5 . If one takes into account
corrections for possible hydrogen bond formation
between polar residues and water, a linear relation
between accessible surface area and hydrophobicity
is obtained and may be expressed as a molar energy
w xof transfer from water to the nonpolar solvent 5 . On
the other hand, the diffusional properties of the mem-
brane are strongly heterogeneous. At least two dis-
tinct regions can be identified, the highly polar inter-
w xface and the hydrocarbon interior 3 . Unlike a bulk
solvent, permeabilities in biological membranes and
model bilayers depend strongly on the volume of the
w xdiffusing molecule 1,6 .
Detailed analysis of the peptide partitioning be-
tween water and lipid bilayers reveals the complexi-
ties of this phenomenon. There are several effects
that contribute to the partitioning of the peptide
molecule between water and the lipid bilayer. Besides
the aforementioned hydrophobic effect there is the
peptide immobilization effect, conformational
changes of peptides, intermolecular hydrogen bonds,
membrane lateral pressure and lipid perturbation,
which generally oppose the transfer of peptides from
w xaqueous to lipid phase 7–9 . The overall character of
the peptide transfer process e.g., endothermic or
.exothermic is determined by the subtle interplay of
all the contributing effects. All of those specificities
of the partitioning and interfacial interactions lead to
the conclusion that bulk-phase measurements are in-
w xadequate for describing bilayer partitioning 10 . Un-
derstanding of the mechanism of the transmembrane
movement has practical significance, because the per-
meability of biological membranes that constitute the
blood–brain barrier is a major obstacle in peptidic
w xdrug delivery to the brain 11 . Since the require-
ments for biological activity and permeability are not
necessarily convergent, this creates an additional
challenge for the development of peptidic drugs.
Here we describe studies of the permeation of the
octapeptide biphalin across model membranes.
w . xBiphalin Tyr–D-Ala–Gly–Phe–NH is a most po-2
tent analgesic enkephalin analogue and in fact is
w xmore potent than most alkaloid opiates 12–14 . The
affinity of this highly flexible peptide toward d- and
m-opioid receptors can be partially controlled by
various substitutions in the para position of Phe4,4
X
w x14 . The efficacy of this analgesic relative to other
peptides is improved due in part to its modest perme-
w xability of the blood–brain barrier 11,13,15 . In order
to analyze the permeability and partitioning of
biphalins, we have used a model membrane com-
posed of neutral phospholipids and cholesterol, repre-
senting the major lipid components of vasculature
membranes. The goal is to correlate the permeation
and partition coefficients of the peptides with the
para-substituent on the biphalins.
2. Materials and methods
2.1. Materials
The following lipids: 1,2-dipalmitoylphosphatidyl-
 .c h o l i n e D P P C , 1 - p a l m i t o y l - 2 -
 .oleoylphosphatidylcholine POPC and 1-palmitoyl-
 .2-oleoylphosphatidylethanolamine POPE , were pur-
chased from Avanti Polar Lipids, Alabaster, AL.
Hepes and Hepps were purchased from Calbiochem,
La Jolla, CA, sodium azide and sodium chloride from
Aldrich, Milwaukee, WI, cholesterol and Triton TX-
100 from Sigma, St. Louis, MO. Degassed Hepes
buffer 10 mM Hepes, 150 mM sodium chloride, 1
.mM sodium azide, 0.1 mM EDTA, pH 7.4 or Hepps
buffer 10 mM Hepps, 150 mM sodium chloride, 1
.mM sodium azide, 0.1 mM EDTA, pH 8.9 was used
throughout the experiments. Dialysis membranes were
purchased from Spectrum, Houston, TX. Leu–en-
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 .kephalin Tyr–Gly–Gly–Phe–Leu and Tyr–D-Ala–
Gly were purchased from Bachem, Torrance, CA,
 .whereas biphalin Tyr–D-Ala–Gly–Phe–NH and its2
analogues, were synthesized as described elsewhere
w x12 .
2.2. Permeability assay
Following the method developed in our laboratory
w x16 , 20 mg of a dried mixture of lipids and choles-
 .terol was hydrated in 1 ml of Hepps buffer pH 8.9
and sonicated to form homogenous suspension. The
desired peptide was added and the mixture was vigor-
ously stirred, frozen and thawed to form extended
bilayers, which were then extruded at 408C through
w xpolycarbonate filters with a pore size of 200 nm 17 .
Liposomes, with trapped peptides, were separated
from untrapped peptides by size exclusion chro-
matography on a Sephacryl S-300 column. A 2 ml
fraction of liposome suspension was placed in a
dialysis membrane bag and the pH was adjusted to
7.4. The dialysis system was designed specifically for
this assay. A sample placed in the dialysis bag is
dialyzed against 200 ml of buffer. The dialyzate is
continuously pumped at the flow rate of 1.2 ml hy1
and the sample collected in 1.2 ml fractions by an
automatic fraction collector. To assure the stability of
the experimental conditions, the ambient temperature
is thermostated at 258C and the dialyzate is continu-
ously stirred. All parts of the dialysis system are
 .made of poly methyl methacrylate to minimize ad-
sorption of peptides on its surfaces. The amount of
peptide molecules released form liposomes into the
dialyzate was determined by a fluorescamine assay
w x18 . The intensity of fluorescence excited at 380 nm
and measured at 480 nm was used to quantify the
peptide concentration. The permeability data were
analyzed by the procedure of Johnson and Bangham
w x19 which yields the following equation
NV NV V qVout out out inln yN t s ln yk t .
V qV V qV Vin out in out out
1 .
 .where N t is the number of peptide molecules in
dialyzate at given time, N is the number of peptide
molecules in liposomes at ts0, V is the volume ofout
the dialyzate, V is the volume of the liposomein
suspension contained in the dialysis bag, finally ks
 .ArV P, where A is the surface area of the inside
liposomes, V is the internal volume of the liposomes
and P is the permeability coefficient.
To estimate the number of peptide molecules ini-
tially trapped in the liposomes, we applied the follow-
ing procedure. First, the liposomes were sized by
dynamic light scattering, as described previously
w x16,20 . The apparent liposome diameter with en-
trapped peptides varied between 146 and 155 nm.
The lipid content was determined by the ammonium
w xferrothiocyanate assay 21 , as described in detail
w xelsewhere 22 . The liposome diameter together with
the lipid amount were used to calculate the total
liposome volume. Finally, the peptide concentration
inside the liposomes was assumed to be equal to the
initial concentration of peptides in the lipid suspen-
sion before extrusion, which leads to the trapped
 .amount of peptide, N. Eq. 1 represents a linear
function of t, which allows for a calculation of the
permeability coefficient, P, by the method of least
squares. An alternative method was evaluated for
determining the number of peptide molecules initially
trapped in the liposomes, i.e., Triton X-100 lysis of
the liposomes followed by the fluorescamine assay of
the released peptides. However, the presence of Tri-
ton X-100 strongly affects the intensity of the fluo-
rescamine–biphalin complex fluorescence. The pres-
ence of the detergent perturbs the N-termini accessi-
Table 1
Permeability and partition coefficients
Peptide Permeability Partition
coefficient coefficient
y12 y1 .10 cm s
X4,4w xp-F-Phe -biphalin 2.58"0.67 2188"324
X4,4w xp-I-Phe -biphalin 1.05"0.21 ND
X4,4w xp-Cl-Phe -biphalin 1.01"0.12 1460"38
biphalin 0.68"0.15 861"121
X4,4w xp-NO -Phe -biphalin 0.29"0.02 -1002 X4,4w xp-NH -Phe -biphalin 0.22"0.02 130"522
Leu–enkephalin 3.80"0.46 ND
Liposomes composed of POPC:POPE:cholesterol at the molar
ratio 65:25:10 served as a model membrane. Concentration of
peptides was determined by intensity of the intrinsic fluorescence
 .due to tyrosine for the partition coefficient determination or by
extrinsic fluorescent probe, fluorescamine for the permeability
.coefficient .
ND: not determined.
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bility to interactions with fluorescamine, preventing
quantitative analysis by this assay.
The above method is not corrected for the biphalin
peptide that resides in the lipid phase. The partition
coefficient, K , can be used to calculate the molar
concentration of peptides in the membrane, C p, andm
aqueous phase C p where C p sC p yC p, and C l isa a tot m m
the molar concentration of lipids and C w is the watera
concentration. Using the relationship
1
p pC sC 2 .a tot l w1qK C rC .m a
it can be shown that for a K of 103, the value of C pa
is 5r6 of the original C p , and for a K value of 102,tot
the C p value is 50r51 of C p . These errors area tot
similar or less than the uncertainties cited in Table 1.
2.3. Equilibrium dialysis
We have developed an equilibrium dialysis assay
to determine partitioning of the opioid peptides be-
tween the aqueous phase and model membranes.
Each dialysis cell is separated by a cellulose dialysis
membrane, average MW cut off 12 000–14 000. 1 ml
of ca. 0.1 mM peptide solution in buffer is placed on
the cis side of the membrane, whereas 1 ml of a lipid
suspension in the same buffer is placed on the trans
side. In the experiments performed, the five cells
contained 40, 30, 20, 10 and 0 mM lipid suspension.
Samples were equilibrated overnight in a water bath,
using five cells mounted in a rotor that ensures
homogeneity of peptide and lipid distribution in the
dialysis cells. After the equilibration time, the con-
centrations of peptides on the cis side therefore
.unbound were determined by measurements of the
intrinsic peptide fluorescence all peptides under study
.contain tyrosine . Data were analyzed using a nonsat-
urable partitioning model, which yields the partition
coefficient:
I K L0 s q1 3 .
I 2 W
where I is the intensity of fluorescence, I is the0
intensity of fluorescence in the cell with no lipids on
w xthe trans side, L is the concentration of lipids in the
w xtrans compartment, W is the concentration of water,
K is the partition coefficient, and factor 2 is to
correct the lipid concentration for the doubled vol-
ume accessible to the peptides, i.e., the cis and trans
compartment volume, rather than trans only. The
total volume of the sample was taken into considera-
tion. At equilibrium both the interior and exterior
aqueous compartments are equivalent. The volume of
the lipids was not subtracted, since it is less than 2%
of the total. This method does not limit the lipid
system used in the experiments, therefore it is possi-
ble to use the same lipid composition as that used in
the permeability experiments. The lipid suspension
was prepared following the method described in Sec-
tion 2.2, except no peptide was added to the suspen-
sion.
2.4. Differential scanning calorimetry
Peptide molecules penetrating a membrane perturb
the lipid order of the membrane. The extent of this
perturbation can be determined by measuring the heat
capacity profile of the lipid phase transition. Hence
 .differential scanning calorimetry DSC is a conve-
nient tool for characterizing peptide-membrane inter-
actions. Preparation of the lipid suspensions and
calorimetric measurements were performed in a simi-
w xlar manner as described by Ramaswami et al. 16 .
Multilamellar lipid suspensions were prepared from 1
mg DPPC hydrated with 1 ml of Hepes buffer pH
.7.4 . A desired amount of a peptide was added and
suspension was mixed and incubated at 41.58C for ca.
12 h. Calorimetric measurements were performed
immediately after the sample incubation. The mea-
 .surements were repeated at different decreasing
concentrations of peptides. These concentrations were
adjusted by adding aliquots of the lipid suspension,
and sample was again mixed and incubated for ca. 12
h prior to the measurement. To monitor the possibil-
ity of hydrolysis of the DPPC, the sample was ana-
 .lyzed by thin layer chromatography TLC . The elu-
ent was a mixture of chloroform:methanol:water
 .65:25:4 and the TLC plate was stained by phospho-
molybdic acid. Only one spot was detected over the
duration of the experiment.
DSC measurements were performed with a Micro-
cal MC-2 scanning calorimeter Microcal, Northamp-
.ton, MA interfaced to a 486 PC computer. Both
 .sample and reference buffer cells were pressurized
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 .40 psi, nitrogen and heated at a constant rate of 10
deg hy1. Collected thermograms were normalized
and baseline was subtracted to obtain excess heat
capacity curves. Analysis of these curves yields the
temperature at the maximum of excess heat capacity,
T , calorimetric enthalpy, D H , and van’t Hoffm cal
enthalpy, D H . The size of cooperative unit, CU,vH
was calculated as a ratio of the van’t Hoff enthalpy to
the calorimetric enthalpy.
2.5. Spectroscopic assays
 y.The iodide I quencher stock solution was pre-
pared as a 2 M KI solution with 1 mM Na S O ,2 2 3
added to prevent formation of I , in the Hepes buffer,2
 2y.described above. The hypophosphate HPO4
quencher was prepared as a 1 M Na HPO solution2 4
in the Hepes buffer. The final pH value of these
solutions was adjusted to pH 7.4 using NaOH or HCl
as needed. The quenching experiment was performed
in a 4 ml cuvette using a 0.1 mM or less concentrated
peptide solution. The quencher stock solution was
added to obtain the quencher concentrations between
10 and 200 mM. Fluorescence of the peptide due to
tyrosine was excited at 275 nm and intensity at 305
nm was recorded as a function of the quencher
concentration. The data were analyzed using the
Stern–Volmer equation,
I
sK Q q1 4 .DI0
where: I is the fluorescence intensity, I is the0
fluorescence intensity in the absence of the quencher,
w xQ is the quencher concentration, and K is theD
Stern–Volmer quenching constant. Fluorescence in-
tensities were corrected for the dilution due to the
added quencher. The linear correlation coefficient
was calculated to evaluate linearity of the data. All
fluorescence spectra were recorded using a Spex
Fluorolog spectrofluorometer.
Spectrophotometric titrations were performed as
follows. Unbuffered ca. 0.1 mM solution of a peptide
was used. The pH of the solution was varied by
adding NaOH. Total dilution of the sample due to the
base added did not exceed 5%. Absorption spectra
were recorded using a Varian DMS-200 spectro-
photometer. The absorbance at 290 nm as a function
of pH was plotted and analyzed to obtain the pK . Ina
both types of experiments, quenching and pH titra-
tion, biphalin, Leu–enkephalin, and Tyr–D-Ala–Gly,
a non-functional control peptide corresponding to the
N-terminal of biphalin, were compared.
3. Results
3.1. Permeability measurements
The lipids used in this study to prepare liposomes
were a mixture of POPC, POPE and cholesterol in
the molar ratio 65:25:10. The composition were se-
lected as a reasonable first approximation to neutral
lipid membranes. The palmitoyl and oleoyl chains
were chosen to reflect the mix of sn-1 saturated and
sn-2 unsaturated acyl chains. Published phase dia-
grams of saturated PC-cholesterol mixtures indicate
that the lipid bilayer is in the liquid disordered phase
when the cholesterol content is between 10 and 20
mol% and the temperature is at least 158C above the
 .main phase transition temperature T of the phos-m
w xpholipid 23,24 . Since the T values for POPC andm
POPE are below or near room temperature, respec-
w xtively 25 , and there is no evidence of a phase
transition in the POPC:POPE:cholesterol mixture up
 .to 608C DSC scans not shown , it is reasonable to
expect that the model membrane used in these studies
exist in the liquid disordered phase at the experimen-
tal temperature. The liposomes were prepared by
 .extrusion see Section 2 which yields predominantly
unilamellar liposomes of uniform size and narrow
polydispersity as shown by QELS and supported by
w xnegative stain electron microscopy 16 . Although
some oligolamellar liposomes may be present, only
the initial phase of the permeation, which is due to
the outermost bilayer of the liposome, was used to
calculate the permeability coefficient.
The permeability of the bilayer membranes to
various solutes may be measured by dialysis of the
liposome-entrapped solute provided that the rate of
permeation through the dialysis bag is fast relative to
the rate through the bilayer. The measured permeabil-
ity coefficient for biphalins across the dialysis bag
was ca. 10y4 cm sy1, which is many orders of
magnitude faster than the values measured when the
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Fig. 1. Peptide release from phospholipid liposomes
 .POPC:POPE:cholesterol, 65:25:10 as determined by fluo-
 . w 4,4X xrescamine assay. Biphalin B and analogues: p-F-Phe -bi-
 . w 4,4X x  . w 4,4X xphalin I , p-I-Phe -biphalin ‘ , p-Cl-Phe -biphalin
 . w 4,4X x  . w 4,4X x’ , p-NO -Phe -biphalin ^ and p-NH -Phe -biphalin2 2
 .v .
peptides were entrapped in liposomes inside the dial-
 .ysis bag see Table 1 . Detection of the solute can be
accomplished by radiochemical techniques, absorp-
tion and luminescence spectroscopy, as well as enzy-
matic or redox reactions. A convenient peptide assay
 .is the rapid millisecond reaction of the free amino
group with fluorescamine to yield highly fluorescent
 .derivatives excitation 380 nm, emission 475 nm .
This assay is very sensitive with a reported detection
limit of 50 pm for amino acids, and has been used to
detect peptide hormones, e.g., vasopressin and oxy-
tocin in individual rats, and opioids, e.g., b-en-
w xdorphins 26 . Our calibration experiments with fluo-
rescamine gave a detection limit of 2–5 nmol mly1
for biphalin.
The profiles of permeation of the biphalin peptides
 .studied Table 1 through liposomes are shown in
Fig. 1. Only a few percent of the peptides are re-
leased from the liposomes over several hours, which
is much slower than the release from the dialysis
membrane itself. The size exclusion chromatographic
Fig. 2. Analysis of the equilibrium dialysis data. A 0.1 mM
peptide solution was dialyzed against 0, 10, 20, 30 and 40 mM
lipids in a form of liposomes. The peptide concentration in the
aqueous phase after equilibration was determined by fluores-
 . w 4,4X xcence. Biphalin B and selected analogues: p-F-Phe -bi-
 . w 4,4X x  . w 4,4X xphalin I , p-Cl-Phe -biphalin ’ , and p-NH -Phe -bi-2
 .phalin v . The slope of the reciprocal fluorescence intensity
plotted as a function of the lipid concentration is proportional to
the partition coefficient.
separation of the liposome entrapped peptide from
the free peptide requires 30 to 45 min, during which
time only a few tenths of a percent of the encapsu-
lated peptide will escape the liposomes. Therefore,
the fraction of peptides outside the liposomes but
inside the dialysis bag is negligible at the start of the
permeability experiment. The permeability coeffi-
cients of Leu–enkephalin and biphalins, modified by
p-substituents on both phenylalanines, are reported in
Table 1. In general, the halogenated biphalins are
more permeable than the parent biphalin.
3.2. Equilibrium dialysis
The concentration of peptides prepared for this
assay was optimized to assure a sufficient fluores-
cence intensity and, on the other hand, to prevent
possible self-aggregation of peptides. The low solu-
w 4,4X xbility of p-I-Phe -biphalin did not allow prepara-
 . 4,4X  . 4,4X  .Fig. 3. Thermograms for heating scans of biphalin: DPPC a , p-Cl-Phe -biphalin:DPPC b , and p-NO -Phe -biphalin:DPPC c2
 .mixtures. The molar ratio is given at the top of each panel. Values averaged over three consecutive scans of T , H , H and CUm cal vH
 .symbols described in Section 2 are given in each panel. Thermograms shown were obtained with a 1.36 mM suspension of DPPC.
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tion of a sufficiently concentrated sample. The pep-
tide concentration in the aqueous phase was analyzed
by measuring the intensity of the intrinsic fluores-
cence of the peptides. Reciprocal fluorescence inten-
sities are plotted as a function of the lipid concentra-
 .tion in the trans compartment Fig. 2 . The partition
coefficient is proportional to the slope of this linear
 .dependence, as described by Eq. 2 . Partition coeffi-
cients of the halogenated analogues are higher than
 .that of the parent compound, biphalin Table 1 . The
w 4,4X xp-NH -Phe -biphalin analog shows very low par-2
titioning, that approaches the detectability limit. In-
terestingly, the observed partition coefficients of the
biphalins parallel the permeability measurements, in-
dicating that the relative permeabilities of these pep-
tides is dependent on biphalin partitioning.
The detection limit of this assay was determined as
follows. Assuming the reproducibility of the fluores-
cence measurements to be 5% and considering the
range of lipid concentration, 0 to 40 mM, the lowest
value of the reproducibly detected partition coeffi-
cient is ca. 100. If the peptide studied here has the
partition coefficient of this order of magnitude, i.e.,
p-NO -Phe4,4
X
-biphalin, the measured partition coeffi-2
 .cient was indicated as -100 Table 1 .
3.3. Differential scanning calorimetry
The excess heat capacity curves for mixtures of
w 4,4X x wDPPC with biphalin, p-Cl-Phe -biphalin or p-
4,4X xNO -Phe -biphalin are presented in Fig. 3. Increas-2
ing concentrations of these peptides induced distinc-
tive changes in the thermodynamic properties.
Biphalin increases the main transition temperature of
 . wDPPC 41.528C for pure DPPC , whereas p-Cl-
4,4X x w 4,4X xPhe -biphalin and p-NO -Phe -biphalin reduce2
this temperature. Even at the highest peptide-to-lipid
 .molar ratio 1:2 these changes do not exceed 0.88C.
However perhaps the most obvious effect that accom-
panies the peptide–lipid interaction is the reduced
size of the lipid cooperative unit at this concentration
of peptides. The cooperative unit size is reduced to
149, 178 and 386 lipid molecules when interacting
w 4,4X x wwith biphalin, p-Cl-Phe -biphalin or p-NO -2
4,4X xPhe -biphalin, respectively, as compared to ca. 600
for a pure phospholipid suspension. This results from
a significant change of van’t Hoff enthalpy rather
than calorimetric enthalpy, which remains relatively
constant. This behavior of the van’t Hoff and calori-
metric enthalpy indicates that the peptide upon enter-
ing the model membrane does not interact strongly
with lipids and does not prevent individual lipid
molecules from conformational rearrangements char-
acteristic of cooperative membrane behavior. The
w 4,4X xincreasing biphalin or p-Cl-Phe -biphalin concen-
tration decreases the excess heat capacity at the tran-
sition temperature, however this effect is not obvious
w 4,4X xfor p-NO -Phe -biphalin. Finally, it can be noted2
that the peptides which reduce the phase transition
w 4,4X x wtemperature, i.e., p-Cl-Phe -biphalin and p-
4,4X xNO -Phe -biphalin, efficiently remove the pretran-2
 .sition at 358C Fig. 3 .
3.4. Spectroscopic assays
The pK values determined for the tyrosine hy-a
droxyl groups of biphalin, Leu–enkephalin and the
Tyr–D-Ala–Gly model peptide are identical within
 .the experimental error Fig. 4 and Table 2 . The pKa
values determined for these peptides are within the
range typical for solvent accessible tyrosine residues
w x27 , and agree with the previous determination of
w xpK for Leu–enkephalin 28 . Typically, it is prefer-a
 .Fig. 4. Spectrophotometric titration curves of biphalin B ,
 .  .Leu–enkephalin ’ and Tyr–D-Ala–Gly v . The curves repre-
sent absorbance at 290 nm, characteristic of the deprotonated
form of tyrosine, as a function of pH. The absorbance values
were used to quantify the extent of deprotonation. The pK valuea
 .was interpolated from the fitted sigmoidal Boltzman curve as
pH corresponding to 1r2 of the total increase of the absorbance
due to the deprotonation.
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Table 2
Analysis of spectrophotometric titration and fluorescence quench-
ing experiments
aPeptide pK Stern–Volmer quenchinga
b y1 .constant , K MD
y 2yI HPO4
Biphalin 9.89"0.01 5.00"0.03 2.91"0.03
Leu–enkephalin 9.96"0.01 4.51"0.03 2.61"0.05
Tyr–D-Ala–Gly 9.97"0.01 6.86"0.10 3.40"0.04
Fluorescence quenching experiment was performed by adding 1
M iodide or 2 M hypophosphate quencher stock solution to
obtain quencher concentration between 10 and 200 mM. In
spectrophotometric titrations, the pH was varied by adding con-
centrated NaOH.
a The pK values were obtained by fitting a sigmoidal Boltz-a
.man curve to the experimental data points. The reported experi-
mental error reflects the quality of the fitting procedure. How-
ever, considering experimental uncertainties due to the sample
concentration, we estimate the experimental error as "0.1.
b The Stern–Volmer constants were obtained by linear regres-
sion. The raw data were corrected for the sample dilution due to
the added quencher in the experiment.
able to analyze the ratio of the deprotonated-to-proto-
nated tyrosine absorbance, A rA , in order to290 275
eliminate errors due to sample concentration changes.
However, the spectral shape change in the region
adjacent to 275 nm observed for biphalin precluded
 .this approach Fig. 5 ; instead the absorbance was
analyzed using the deprotonated form of tyrosine,
centered at 290 nm. Considering the steep absorbance
vs. pH dependence approximately D A rDpHs290
.0.1 and the dilution of -5% of the initial volume,
the resulting experimental uncertainty is about 0.1
pH.
Titration of biphalin results in different spectral
changes below 275 nm the wavelength of L transi-b
.tion of tyrosine as compared to both Tyr–D-Ala–Gly
 .and Leu–enkephalin Fig. 5 . The band centered at
 .  .Fig. 5. Absorption spectra of a biphalin, b Leu–enkephalin,
 .and c Tyr–D-Ala–Gly at increasing pH values, from 7.4 to
11.8. Arrows indicate direction of spectral changes due to the
increased pH value. Ca. 0.1 mM unbuffered solution of each
peptide was titrated using NaOH. The emerging band at 290 nm
is used for quantitative analysis of the deprotonated form of
tyrosine. The spectral shape of biphalin at higher pH interferes
with a reliable determination of absorbance at 275 nm character-
istic of the protonated tyrosine.
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238 nm, present in both deprotonated Tyr–D-Ala–Gly
and Leu–enkephalin, is much stronger, broader and
red shifted in biphalin. Analysis of the high pH
spectra of these peptides shows that this broad ab-
sorption band found for biphalin can be separated
into that present in Tyr–D-Ala–Gly or Leu–enkepha-
lin, centered at 238 nm, and an additional band
 .centered at 246 nm Fig. 6 . This relatively strong
band changed the appearance of the biphalin spectra
at higher pH, as compared to the other peptides
 .studied Fig. 5 , and interfered with the determination
of the absorbance of the protonated form of tyrosine
at 275 nm. This band is tentatively attributed to the
hydrazide bridge of biphalin.
The quenching of tyrosine fluorescence by iodide
 .and phosphate anions was also analyzed Fig. 7 .
Quenching measurements can reveal accessibility of
w xfluorophores to quenchers 29 . Fluorescence quench-
ing by iodide is probably a result of intersystem
crossing to a weakly luminescent excited triplet state.
This intersystem crossing is promoted by spin-orbit
coupling within the phenolic ring which is enhanced
w xby the presence of iodide 30 . The proposed mecha-
nism of the tyrosine quenching by phosphate ions
involves formation of a hydrogen bond between the
hydroxyl group of the excited state tyrosine and the
Fig. 6. Analysis of absorption spectra of the tyrosine containing
 .peptides at high pH values ca. pH 11.5 , above the pK of thea
tyrosine hydroxyl group. Absorption spectrum of biphalin dashed
.  .  .line , Leu–enkephalin dotted line , and the difference solid line
are shown. The differential spectrum represents a band centered
at 246 nm, characteristic of biphalin but not Leu–enkephalin or
Tyr–D-Ala–Gly.
 .  .Fig. 7. Iodide A and hypophosphate B quenching of fluores-
 .  .cence of biphalin B , Leu–enkephalin ’ and Tyr–D-Ala–Gly
 .v . The linear Stern–Volmer plots were obtained based on the
intensity of fluorescence excited at 275 nm and detected at 305
nm. The concentration of peptides did not exceed 0.1 mM. The
fluorescence of Tyr–D-Ala–Gly is quenched more efficiently
than that of Leu–enkephalin or biphalin.
 y.  . w xphosphate anion: –OH . . . OP O OH 31 . The2
tyrosine side chain appears to be less accessible in
biphalin or Leu–enkephalin than in the model pep-
 .tide, Tyr–D-Ala–Gly Table 2 . The Stern–Volmer
constants for biphalin or Leu–enkephalin fluores-
cence quenching are lower than that obtained for the
Tyr–D-Ala–Gly model peptide. With all three pep-
tides, the Iy quenching is more efficient than HPO2y.4
4. Discussion
Our interest in the interaction of different biphalin
analogs with model membranes was prompted by our
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initial observation that the transfer of biphalins from
aqueous phase to model membranes is driven by
enthapy change rather than the entropy changes char-
w xacteristic of the hydrophobic effect 32 . In that ex-
periment, a lipid vesicle suspension was titrated into
w 4,4X xa solution of p-Cl-Phe -biphalin, one of the more
permeable biphalin analogues. In fact, we found that
the overall interaction between the peptide and mem-
brane was exothermic, therefore driven mostly by
enthalpy changes, rather than an entropy increase.
Previously, we analyzed a series of conformationally
w 2 5xrestricted cyclic D-Pen ,D-Pen -enkephalin analogues
modified on the position 3 by increasingly hydropho-
3 3 3 3 w xbic side chains Gly “ Ala “ Abu “ Phe 33 .
In that series, we observed that the increasing perme-
ability coefficient depends linearly on the hydropho-
w xbicity of the substituted side chains 33 , and that
indeed the peptide–membrane interaction was en-
w xtropy driven 32,34 . Furthermore, the permeability of
more flexible, but larger octapeptide, i.e. biphalin, is
w 2greater than that of the pentapeptide cyclic D-Pen ,D-
5x w xPen -enkephalin 33 . Thus, the mechanism of trans-
membrane permeation of flexible biphalins differs
substantially from that of conformationally restricted
peptides.
Differential scanning calorimetry demonstrates that
the interaction between biphalins and lipid molecules
within a membrane is rather weak. It is evident that at
the peptide-to-lipid molar ratios used in the perme-
ability assays and equilibrium dialysis experiments,
not exceeding 1:20, the presence of peptides does not
 .affect the phase behavior of lipid membranes Fig. 3 .
This is similar to the observation of Ramaswami et
w x wal. 16,33 concerning the interaction of cyclic D-
2 5xPen ,D-Pen -enkephalin analogues with the same
type of model membranes. The observation that the
lipid membrane is essentially unperturbed upon the
peptide entering membrane supports the passive dif-
fusion model of the transmembrane movement of
w xthese agents 3 . According to this model, the ob-
served permeation coefficient is a product of the
water–membrane partition coefficient and transmem-
brane component of the diffusion constant. The mea-
sured values of the permeation and partition coeffi-
 .cients Table 1 are well correlated, both being lower
for electron withdrawing substitutions and higher for
the electron donating substitutions as compared to the
parent compound, biphalin. To understand how the
biphalin structure and its modifications control the
observed partitioning and permeability, we propose
that the flexible biphalin can adopt a folded confor-
mation similar to that observed in the Leu–enkepha-
w xlin trihydrate crystal structure 35,36 . Both peptides
have similar amino acid sequence and comparable
w xaffinities for the m- and d-opioid receptors 14 . The
 .membrane permeability of Leu–enkephalin Table 1
w 2is similar to that of the reduced acyclic D-Pen ,D-
5x w xPen -enkephalin 16 . Both of these acyclic peptides
w 4,4X xare about 40% more permeable than p-F-Phe -bi-
phalin. To evaluate the folding of biphalin and Leu–
enkephalin the accessibility of the aromatic side
chains of these peptides, essential for their biological
function, was compared by spectroscopic assays.
Consequently, we examined whether the type of fold-
ing identified for Leu–enkephalin provides a firm
basis for explaining the permeability and partitioning
of biphalins.
The spectrophotometric titration does not reveal
any differences in the solvent accessibility of the
hydroxyl group of the tyrosine residues of biphalin,
Leu–enkephalin or the Tyr–D-Ala–Gly model pep-
tide. Unlike the pH titration experiment, the fluores-
cence quenching study indicates different tyrosine
side chain accessibilities among the peptides being
tested. The Stern–Volmer constants reveal that acces-
sibility of the tyrosine residue in Leu–enkephalin and
biphalin is lower than in the Tyr–D-Ala–Gly Table
.2 . Analysis of the three dimensional structure of
Leu–enkephalin, which is more complete than
biphalin, provides some interesting insights into the
possible mechanism of quenching. It is accepted that
enkephalins in solution exist as an equilibrium of
w xdifferent conformers 36–38 . The three dimensional
structures observed for this peptide can be classified
w x X  . w xas extended 39 , type I b-turn single b-turn 40
 . w xand bIIIrbI-folded fused two b-turns 35 . The
bIIIrbI-folded structure of Leu–enkephalin trihy-
w xdrate 35,36 , is characterized by almost orthogonal
close contact between the Tyr1 and Phe4. The tyro-
sine and phenylalanine rings form a face-to-edge
oriented pair, characterized by the center-to-center
˚distance of 4.99 A and the angle between the planes
 . w x1018 118 different from perpendicular 35 . In this
conformation of Leu–enkephalin, the phenylalanine
residue forms a shallow pocket partially limiting
solvent accessibility to the tyrosine fluorophore. The
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presence of this folding of Leu–enkephalin in the
conformational equilibrium in solution will reduce
the quenching efficiency as observed experimentally.
It has been shown that the mutual position of the
aromatic side chains of tyrosine and phenylalanine is
crucial for d- or m-receptor selectivity of peptide
w xligands 41–43 . The analogous drm affinities and
sequence similarities of Leu–enkephalin and biphalin
indicate that the folded arrangements of the
tyrosine–phenylalanine aromatic side chains, which
Fig. 8. Folded structure of biphalin. The proposed model com-
prise two b-turn motifs and a rigid hydrazide bridge. This
structure is stabilized by four intramolecular hydrogen bonds, and
possibly by formation of aromatic ring pairs, Tyr1–Phe4X and
Tyr1X –Phe4. This specific folding motif explains the chiefly
enthalpic character of water-to-lipid transfer of this peptide and
the role of different substituents in the para position of phenyl-
alanine in the observed permeability of biphalin analogues see
.Section 4 .
were previously identified in the Leu–enkephalin
trihydrate crystal structure and are suggested to be
crucial for m-receptor recognition, are likely to also
contribute to the conformational equilibrium of
biphalin. The observed changes in cross-membrane
permeation and water–membrane partition of
 .biphalins Table 1 generally correlate with the elec-
tron affinities of the groups substituted at the para
position of the benzene ring of Phe4 and Phe4X of
biphalin. The permeability coefficient increases in the
following order of substituents: p-NO -p-Cl, low-2
est for the electron withdrawing substitution and
largest for p-electron donating substitution. The ar-
rangement of Tyr1 and Phe4 residues of Leu–en-
kephalin trihydrate crystal closely resembles a typical
˚Tyr–Phe aromatic pair, characterized by a 5.74 A
centroid distance, and a dihedral angle of 578 238
.different from perpendicular , that is known to con-
tribute as much as negative 1–2 kcal moly1 to the
w xstability of a molecule 44 . The geometry of interact-
ing aromatic pairs results from electrostatic interac-
w xtions between electron clouds of the rings 44,45 .
The potential energy favors an edge-to-face orienta-
tion because the aromatic H atoms are positively
charged and the C atoms are negatively charged with
respect to one another. Substituents having p-elec-
tron donating character, e.g., p-Cl or p-F will en-
hance this electrostatically driven aromatic ring inter-
action, and increase the folded population of these
peptides. The opposite can be expected for, p-NO .2
Based on theoretical and experimental considerations,
 .it is accepted that folded compact conformers of
otherwise flexible short peptides are energetically
favorable within a membrane and the presence of
such compact structures favors water-to-membrane
w xpartitioning of peptides 7,46,47 . Although the single
X w xtype I b-turn motif 40 does not allow close contact
of Tyr1 and Phe4 in Leu–enkephalin, two such turns
in a molecule having two tyrosines and two pheny-
lalanines, such as the case with biphalin can create a
Tyr1 ¡ Phe4X or Tyr1X ¡ Phe4 pair. This possibility
X w xis illustrated in Fig. 8 where two type I b-turns 40
are joined by the rigid hydrazide bridge whose con-
formation is known from the crystallographic analy-
w xsis of di-L-phenylalanine hydrazide 41 .
Our observations emphasize the possible impor-
tance of conformational changes that promote the
efficient transmembrane movement of biphalins. It
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can be anticipated that such changes will be entropi-
cally unfavorable, possibly offsetting the hydrophobic
effect. A relatively low entropic gain may be charac-
teristic of water-to-membrane partitioning of small
peptides that do not posses a stable conformation in
water, and have to fold in order to enter a membrane.
Among all compact conformers of that peptide, those
that minimize the number of hydrogen bonds with
water will enter the membrane most efficiently. Al-
though it is well recognized that folding of large
peptides facilitates their membrane association, the
application of this principle to small peptides appears
to useful for enhancing the membrane permeability of
these important molecules. In the case of biphalins
studied here, the selection of substituents that favor
the formation of folded conformations enhanced the
permeability by an order of magnitude.
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